UNC scientists coordinate study of link between insulin use and cancer in people with diabetes
Monday, December 14, 2009 - 15:14
in Health & Medicine
Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a higher risk of certain cancers than other insulins or oral glucose lowering medications. However, these studies were unable to control for important factors such as obesity that may have driven the association.